About this episode

The episode discusses recent findings on melanoma reduction from sunscreen use and the implications of GLP-1 receptor agonists and SGLT2 inhibitors on various health conditions.

Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy * Previously discussed on Fornight XXII: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Explore listener stats, chart rankings, contacts and more on the Sensible Medicine podcast page.